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Phenylketonuria (PKU) is a genetic disorder caused by the deficiency of the enzyme, 
phenylalanine hydroxylase. Phenylalanine accumulation in brain causes cognitive impairment 
and behavioral problems, which can be prevented by dietary restriction of phenylalanine. People 
with PKU have to maintain a highly restrictive low protein diet throughout their entire life. PKU 
is typically diagnosed at birth through newborn screening. In order for a patient to reach their 
optimal IQ and health status, they need to maintain their blood phenylalanine (phe) level within 
the recommended range of 60-360 µmol/L.   
The purpose of this study is to investigate attitudes of adults diagnosed with 
phenylketonuria (PKU) and how they relate to their actions of management therapy 
recommendations. Adults with PKU completed an online survey through Survey Monkey.  After 
receiving consent via email, the survey link was sent to them so they completed it at their 
convenience. The study asked questions such as, how often they tested their blood phe level and 
compared that to how often their clinic recommends getting tested. Then subjects were asked on 
a scale of one to five (with five meaning they strongly agree) if they agreed that getting their 
blood phe level tested as often as their clinic recommends is important. From the data we 
gathered information about different management practices, the perceived importance of certain 
dietary management practices, and whether certain factors, such as relationships between patient 
and clinic influence dietary management. There was no set universal method for counting phe 
intake. While there are three main methods, the two that were used the most were by counting 
exactly using milligrams (mg) of phe and the other was an estimation of counting in grams of 
protein. It was also found that the relationship with the clinic may have an impact on dietary 
management. Patients who had a good relationship with their clinic were more likely to follow 
their daily protein restriction, test their blood phe level more often, and realize the importance of 
testing their blood phe level as often as their clinic recommends.  
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 Chapter 1:  Introduction 
People diagnosed with phenylketonuria (PKU) have to maintain a highly restrictive low 
protein diet throughout their entire life. PKU is a genetic disorder that results in a deficiency of 
the enzyme, phenylalanine hydroxylase. This enzyme breaks down the amino acid, 
phenylalanine, into another amino acid, tyrosine, making tyrosine an essential amino acid in 
patients with PKU. Along with a low protein diet, an amino acid formula (excluding 
phenylalanine) has to be consumed to provide adequate protein. If excess phenylalanine builds 
up, it metabolizes into toxic substances and causes problems in thinking and behavior. PKU is 
typically diagnosed at birth through newborn screening programs. However, if it is not caught 
and treated, the patient will become significantly mentally challenged for a lifetime. In order for 
a patient to reach their optimal IQ and health status, they need to maintain their blood 
phenylalanine (phe) level within the recommended range of 60-360 µmol/L. (Waisbren, 2007). 
As with any chronic disease PKU is very complex and successful management involves many 
factors.  
 
Chapter 2:  Review of Literature 
Management of the Disease: Practices of Health Professionals.  
Health professionals play a major role in dietary management. To increase understanding 
of current PKU management practices in health clinics, Blau et al. (2010) sent out a survey to a 
variety of health professionals who were involved in metabolic clinics all across Europe. Main 
focuses of the survey included general information about the center (such as number of patients, 
and definition of hyperphenylalaninemia), screening practices, treatment practices, follow up 
practices, and use of existing guidelines and protocols. In the end, 93 treatment centers from 19 
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countries returned the survey in which a total of 14,837 PKU patients were on record. Of these, 
only 12, 409 PKU patients were seen per year for follow-ups. Only 12% of the 93 centers 
provided a full team coverage including physicians, dietitians/nutritionists, specialty nurses, 
psychologists and clinical biochemists. While there was a general consistency of the definition of 
classical PKU, moderate and mild PKU classifications were inconsistent between centers, even 
centers within one country. There was also a discrepancy as to at what blood phe concentration 
treatment should begin and only about half of the centers reported using the protocols from their 
center. Their results indicated an great need for a joint European guideline for the management 
of PKU (Blau, 2010).  
While there needs to be an established international set of guidelines for treating patients 
with PKU, it should also include guidelines for infants with PKU as well. Portnoi et al. 1999 sent 
out a survey to experienced dietitians who work with PKU patients from nine clinics in the 
United Kingdom (UK) and four in Australia. These dietitians were overseeing a total of 63 
infants. Questions from the survey included topics of quantity of amino acids given, the type of 
protein substitute used, use of breast milk versus normal infant formula, energy requirements, 
use of energy supplements and weaning practices. Twenty eight percent of the infants with PKU 
in the UK (n=14) were breast fed while 41% (n=8) of infants were breast fed in Australia. 
According to the UK Medical Research Council, recommendations for amino acids in a 
phenylalanine free formula for normal infants are 3.0 grams/kilogram per day. Twenty-eight per 
cent of the dietitians surveyed reported prescribing less amino acid than recommended. About 
half of the dietitians, 45 percent, suggested solids by three months of age as the volume of 
regular infant formula had to be maintained and infants had increasing appetite. Dietitians varied 
in the method by which they introduced a concentrated protein supplement with 25 percent using 
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a protein substitute with no added vitamins and minerals, half of the dietitians using a protein 
substitute with increased carbohydrates, vitamins, and minerals, and 25 percent of dietitians 
using both methods. This study emphasizes the need to have a universal guideline for 
management practices of PKU.  
It seems that clinicians around the world use similar, but not exact, recommended phe 
levels however; these levels are only a snapshot of that point in time. Health professionals often 
focus on overall mean lifetime blood levels. There is little to no research investigating effects of 
the stability of blood phe levels. A study by Anastasoaie and associates (2008)  looked at the 
possible correlation between Full Scale IQ (FSIQ) and (1) average blood phe levels for each 
participant and (2) consistency of blood phe levels determined by the set standard deviation of 
blood phe level for each subject. Anastasoaie et al. (2008) asked if stability of blood phe is 
related to cognitive outcome in early and continuously treated PKU. Measurements that were 
taken from 46 children included the Wechsler Preschool and Primary Scale of Intelligence, 
Wechsler Intelligence Scale for Children, and Wechsler Abbreviated Scale of Intelligence. There 
was not a significant correlation between standard deviation of blood phe levels and most recent 
FSIQ, but it was closely related at p = .06. This showed a closer relationship than the relationship 
with mean lifetime blood phe level and cognitive outcome. These results may suggest the need 
for an increase in frequency of testing patients’ blood phe levels to monitor fluctuations.  
Factors influencing diet adherence.  
A number of factors affect how well a patient will be compliant. One component of 
dietary management that Olsson, Montgomery, and Alm (2007) looked at was family influence. 
A total of 41 Swedish patients completed a postal questionnaire regarding this topic. There were 
two questions for patients focusing on frequency of amino acid formula intake per day and eating 
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foods on the diet. Questions for parents focused on how parents helped their child; if they take 
time to prepare special food for traveling, celebrations, sickness, and if they planned the diet 
carefully when blood test results arrive. Additional background variables were also in the 
analysis, such as parent’s marital status and education level. Parents’ marital status was the only 
significant relation to phe levels where patients tended to have higher phe levels when their 
parents were separated or divorced. This shows that family roles may have an influence on 
dietary compliance.  
Another study by Crone et al. (2005) explored parental dynamics that may relate to PKU 
patients and their adherence to the diet. A questionnaire was sent out to parents in the 
Netherlands with children, up to age 22, having PKU. It focused on factors such as parent’s 
attitudes, beliefs, subjective norms, emotional reactions, and self-efficacy that may affect the 
patient’s behavior. Before the questionnaire was sent out, the average phe concentrations for the 
children were collected from the previous three years. Out of the 238 questionnaires sent out, 
170 parents filled it out and returned it. Significant results showed decreased average phe 
concentration was seen when parents reported that their child followed the diet, despite 
infrequent higher phe levels and the reported ease of providing the amino acid formula three 
times a day. Increased mean phe concentrations were seen in children with parents reporting 
disapproval from relatives when the child did not follow the diet. This might suggest that 
caregivers and family should be firm with the child’s adherence to the diet but not be harsh.  
Bilginsory, Waitzman, Leonard, & Ernst (2005) were also interested in investigating 
barriers to the diet according to patients and caregivers. A survey was mailed to PKU patients 
and their caregivers in Utah focusing on management of the disease and difficulties of 
compliance. Caregivers were asked to complete each question and children over 10 years of age 
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were asked to complete a division of questions. A total of 32 surveys were returned. There were 
13 subjects over the age of ten who filled out a portion of the survey. With the recommended 
frequency of blood phe testing at once a month, the older cohort of respondents had an average 
number of tests of 6.6 per year. Compliance habits were frequently changed before a blood test 
was taken in 47% of families. Slightly less than half (45%) of subjects agreed that PKU was not 
“a substantial financial burden on their household.” (Bilginsory et al., 2005) Insurance for the 
majority of the families (83%) did not cover the expensive low protein foods. Two main sources 
of strain for caregivers dealt with planning/preparation of meals, and social implications of the 
diet.  
Women of child bearing age particularly need to control their levels in order to prevent 
complications for the fetus. Using focus groups, Kemper et al. (2010), wanted to identify barriers 
and motivators in girls and women in regards to adhering to the diet. The study included 19 
women attending a camp for women with metabolic diseases. Out of the 19 women, 15 women 
had PKU, two had methylmalonic academia (MMA) and the last two had Maple Syrup Urine 
Disease (MSUD). Each focus group was semi-structured and open ended questions covered 
perception of the diet, experience with medical providers and medical home services, and 
transition to adult medical services. Major barriers that were noted were insurance coverage, 
temptation to go off the diet, and potential lack of social support from family and friends. This 
suggests that interventions to help with dietary control need to be customized for each person 
due to the variability of symptoms when the diet is not followed. Other recommendations are 
difficult to improve due to type of insurance coverage. Suggested improvements that can be 
implemented are “educating school officials, expanding roles of metabolic RDs, and assisting 
with transition from pediatric to adult health-care providers” (Kemper et al., 2010). 
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Potential strategies for treatment 
Knowledge of one’s disease may increase successful management of that disease. Bekhof 
et al. (2003) investigated caregivers and patient’s knowledge of PKU and the possible relation to 
average blood phe levels, which indicates level of adherence to the low protein diet. A 
questionnaire was completed by 62 PKU patients (aged 12-22 years old) and parents of 161 
children with PKU (aged 1-22 years old). To measure dietary compliance, the mean blood 
phenylalanine of three years was taken. Out of the 14 total questions, just a little over half of the 
parents and 29 percent of the patients themselves got over 11 correct. Higher knowledge of the 
parents was significantly associated with lower phe levels of their children. This was no longer 
significant after accounting for other confounders, such as severity of the disease, patient’s age, 
education level of the parent, and ethnicity. Psychological and emotional factors may have an 
additional role as knowledge alone did not hold a significant association with diet compliance.  
Durham-Shearer, Judd, Whelan, & Thomas, (2008) expanded on the idea that knowledge 
can be a tool in dietary adherence.  They hypothesized that a patient-focused written education 
resource would be more effective as it would be tailored to patients based on their individual 
needs. An educational packet was formed based on a survey that was mailed to all 177 PKU 
patients seen at the adolescent and adult metabolic clinic at University College London Hospital 
in England. This survey inquired about preference of packet format, such as a booklet, folder, 
etc., and obtained a baseline of knowledge and compliance. A total of 71 surveys were returned 
and subjects who were compliant with the diet, concluded by self-responses and blood phe levels 
from the past six months, were invited to the second phase of the study. Out of the 32 compliant 
subjects, 22 received the custom educational resource, a filofax-style folder with removable 
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inserts. Ten of these subjects were put into a control group and received the resource after the 
completion of the study. All subjects were asked to return a follow up questionnaire after one 
and again after six months. After one month, 23 subjects returned the questionnaire and 22 
subjects returned the questionnaire after six months. Knowledge level significantly increased 
after one month in the intervention group, but the difference was not maintained at six months. 
There was no significant difference in reported intake of protein formula at either follow up. 
Compliance with following prescribed phe intake was significantly greater in the control group 
at one month. This may mean that this resource may be useful as a supportive tool rather than a 
purely educational resource.  
Another potential strategy to help with diet adherence may be to foster positive feelings 
and attitudes in children. Evans et al., 2009 hypothesized that supporting children’s cooking 
skills by providing educational materials might help develop positive attitudes regarding their 
diet.  A group of children from one UK metabolic center helped put together an instructional 
cooking DVD along with a low protein cookbook. Effectiveness of the teaching aids was 
evaluated by a questionnaire containing mostly closed-ended questions and two open-ended 
questions. A total of 102 questionnaires were returned representing 88 families and 105 children. 
About 75 percent of caregivers and children who responded agreed that the resources motivated 
them to explore new recipes. No correlation was observed between median phenylalanine levels 
or number of blood samples along with any of these parameters: frequency of the low protein 
cooking, how useful caregivers found the DVD and book, whether they had tried the recipes, or 
the number of recipes tried.  
To help patients stay motivated to follow the diet, health professionals should also be 
able to understand what the disease is like from the patient’s point of view. Vegni, Fiori, Riva, 
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Giovannini, & Moja, (2009) looked at how various age groups of patients who have PKU 
experience their disease. Forty patients with PKU from the Pediatric Department of the San 
Paolo Hospital of Milan volunteered for the study and were separated into three age groups with 
ten participants in each; 10-year-old age range, 15-year-old age range, 20-year-old and a 25-
year-old age range. Open-ended question interviews conducted by trained psychologists were 
used to collect data. There were two major themes reveled throughout the groups; the internal 
representation of PKU and the understanding of PKU. Each age group had its own challenges, 
but appeared to be going through appropriate development stages. Respondents also showed a 
lack of knowledge about the disease. Vegni et al. (2009) suggested patient education needs to be 
improved and tailored to age as knowledge of the patient may be taken for granted. Suggestions 
for health care professionals were also expressed. Participants wished physicians were more 
personable and understood what having PKU was like.  
 Barriers of management have been a main focus in previous studies and there is a need to 
highlight helpful strategies for patients. Van Rijn et al. (2008) studied the preferred method of 
tracking phe intake in PKU patients. Two main methods include exact measurement or 
estimation. Out of the 327 surveys sent out, 189 were included in the data after returns and 
inclusion criteria. Patient’s responses were divided into three age groups: < 10 years old, 10-15 
years old, and 16-29 years old. Questions looked into attitudes, subjective norms, and perceived 
behavioral control of the patients. Exact and estimation methods were defined for the patients. 
Younger groups tended to use exact measuring methods, and estimation was seen more 
frequently in older patients with only 20% of adult patients reporting using exact methods of 
measurements. There was no association between method of measuring phe intake and blood phe 
levels, although in the 10-15 year old group lower phe levels were seen in patients that used 
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exact methods of measurement. Clinicians may be able to recommend tailored methods for their 
patients in order to control their phe levels.  
 Until recently, strategies only involved what could be done to improve current treatments. 
Developments of new treatments have been advancing faster than ever. A review by van 
Spronsen and Enns (2010) discussed new medical treatments that show promise to increase 
compliance with the diet. It is now general knowledge that the low protein diet needs to be 
followed throughout life, but management methods are inconsistent throughout the world. One 
development in treatment was the discovery of glycomacropeptide (GMP). This is a natural 
protein, derived from goat’s milk, which contains minimal phe. This can potentially be used 
instead of the traditional formula as it has a more palatable taste and may be more effective in 
lowering phe levels. Limitations to this include the need to supplement tyrosine, tryptophan, 
vitamins and minerals. Another promising treatment is an injectable form of the enzyme, 
phenylalanine-ammonia lyase. This enzyme is responsible for breaking down phenylalanine into 
non-toxic compounds, preventing high levels of phe in the body. A recently FDA and EMEA 
approved drug, Kuvan ®, works in patients who are responsive to a substance, (6R)-L-erthro-
5,6,7,8-tetrahydrobiopterin or BH4, which aids in the breakdown of phenylalanine and 
potentially lowers phe levels significantly allowing for a more liberalized diet. The development 
of these treatments has been long anticipated and will significantly impact patients with PKU.  
Summary  
 Successful management involves many complex issues such as overcoming barriers to 
diet adherence while finding what methods work to maintain that adherence, coping with social 
effects that the disease may entail, and being supported by peers and health care professionals. 
Several studies have explored the main barriers to the diet as perceived by patients, caregivers, 
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and clinicians. Main barriers include cost, knowledge of the disease, and inconsistent treatment 
methods.  
There have also been studies on patients’ attitudes and other factors about dietary 
influence. Multiple factors include family dynamics, social support, and knowledge. There is 
minimal research on what patients are doing that they find helpful in managing their diet and 
how important these behaviors are to them. Another point that will influence a patient’s behavior 
is their daily phenylalanine tolerance. If one has a higher tolerance than they may not fully 
comply with their clinic’s recommendations. Someone with a lower tolerance may be aware of 
the consequences of having a high blood phe level and will feel that management practices are 
always important.  
Another essential aspect is relating these behaviors to clinic recommendations. As 
mentioned above, there are inconsistent management guidelines. Patient’s behaviors may be 
related to what their clinic recommends. This may also show healthcare professionals what 
patients are doing and how they feel about it.  
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Chapter 3:  Methodology 
The goal of the present study was to discover attitudes of patients with PKU and how 
they relate to their actions of management therapy. The first hypothesis was adult patients will 
agree that it is important for them to keep track of their phe consumption daily, but they may 
actually keep track of their phe less often. The second hypothesis is that adults will also feel it is 
important to test their blood phe level as recommended but may actually test their blood phe 
level less frequently. An adult with PKU may feel they are familiar with following the diet 
through years of practice, and therefore may not feel the need to test their blood phe levels as 
much as their clinic recommends. The third hypothesis is that patients who feel they have a good 
relationship with their clinic will be more likely to follow the clinic’s recommendations. They 
are more likely to test their blood phe level per clinic recommendations and follow their daily 
restriction every day. If patients feel like their doctor or dietitian really cares about them, then 
they will be more motivated to follow their diet and other recommendations.  
 After obtaining approval from the Institutional Review Board (IRB) and changes in 
protocol (see Appendix A and B), a survey invitation was sent out to select adult patients with 
PKU in the United States. These select patients served to pilot test the survey. Health care 
professionals, which included three registered dietitians and one metabolic disease physician, 
also helped test the survey. After the survey was tested, a survey invitation was sent out to the 
main PKU electronic mailing list that reaches over 1,000 people, although the number of adults 
who actually have PKU on the list is unknown. The invitation also encouraged recipients to send 
the invitation to other possible participants. Possible subjects were also recruited from a PKU 
gathering held in Massachusetts in May 2011. However, there was limited gathering of PKU 
patients in attendance. Participants that qualified had to be diagnosed with PKU, be over the age 
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of 19 years and live in the United States. If someone was interested in participating, they emailed 
the primary researcher with their consent. Once patients responded with consent, a link to an 
online survey was sent to them. After four weeks, a reminder message was sent out to the 
original electronic mailing list. Subjects had two months, from October 2011 to December 2011, 
to complete the survey.  
Questions on the survey revolved around management practices such as: what their daily 
phe allowance is, how patients keep track of their phe intake, how often they keep track of phe 
intake, how often they typically have their blood phe levels tested, and how often they are seen 
for a PKU checkup (Appendix D). Then the surveys asked about their attitudes towards these 
practices. These questions used a Likert type scale and asked the participant to scale how 
strongly they agree with a statement such as: “I feel it is important for me to get tested 
frequently.”  
There were a total of 17 participants, who responded, ten of which were female. 
Participants lived across the United States from the following regions: Midwest (n=6), Northeast 
(n=6), Southeast (n=2), Southwest (n=2), and West coast (n=1). The youngest subject was 19 
years old and the oldest two people were 42 years old.  
Statistical analysis of the data included descriptive statistics in which means, standard 
deviations, ranges, and frequencies were calculated. Inferential statistics were used to determine 
Pearson correlations and possible significant correlations. Significances were determined at p < 
0.05. Hypothesis testing was performed to find possible significant relationships between the 
following; importance of tracking daily phe intake and actual frequency of tracking daily phe 
consumption, importance of testing blood phe levels often and actual frequency of blood phe 
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level testing, and agreement of a good relationship with one’s clinic and frequency of following 
one’s daily protein restriction.  
Chapter 4:  Results 
 A table showing subjects’ daily phenylalanine allowance is shown below (Table 1: Daily 
Phe Allowances). Five of the 17 subjects had a daily phenylalanine allowance of 300-315 
milligrams (mg) of phenylalanine per day. The common rough estimation is 50 mg of phe per 
one gram of protein (Schuett, 2011). Seven subjects had a daily phenylalanine allowance of 350-
700 mg (around seven to fourteen grams of protein). Three subjects had allowances over 1000 
mg of phe. One person had allowance of 3750 mg of phe which is approxamitly75 grams of 
protein. Being able to have 75 grams of protein is unusual for someone with PKU. One 
explanation is that this subject has a form of PKU called benign hyperphenylalanemia when 
phenylalanine levels were tested through new born screening; they were higher than normal, but 
not high enough for a diagnosis of Classical PKU. Patients with hyperphenylalanemia may not 
even need a restricted diet. (Arnold, 2009) Two of the responses of the question were taken out. 
One person responded “Unknown” to the question and one person answered the question “18.” 
This answer was unclear and could mean different things such as 18 grams of protein or 18 phe 
exchanges. In the United States, one phe exchange is equal to 15 mg of phe. By computing the 
Pearson correlation, the amount of phenylalanine allowed per day negatively and significantly 
correlated with subjects who agreed that meeting with a support group will help manage the diet 
(r= -0.589, p = .044,). 
 “Table 2: Methods Used to Keep Track of Daily Phe Intake” shows how subjects keep 
track of their phe intake and if their clinic supports them in their choice of tracking phe.  
Methods used to track phe included; counting milligrams (mg) of phe in foods, using exchanges, 
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and counting by grams of protein.  Using the exchange method, 15 mg of phe is equal to one 
exchange. In counting phe by grams of protein the common estimation is that there is 50 mg of 
phe per one gram of protein (Schuett, 2011). Counting phe by grams of protein is less exact than 
directly counting mg of phe in foods or using the exchange method. In the sample, eight subjects 
reported counting mg of phe in food, three subjects reported using phe exchanges, and seven 
subjects reported counting in grams of protein. Seven people felt that their metabolic clinic will 
support them in whatever method they feel comfortable with. Seven people agreed that the 
method they use is  the method that their clinic recommends. Two people disagree that their 
reported method is one that their clinic recommends and one subject did not know what tracking 
method their clinic recommends.  
 Subjects reported sometimes to how often of keeping track of their phenylalanine 
consumption where keeping track of their phe consumption everyday = 5 and rarely = 1 (M = 3, 
SD = 1.54).  Using Pearson's correlation, subjects keeping track of their phe consumption was 
positively correlated, although not significant, with the agreement that it is important to keep 
track of phe consumed (r = .491, p= .179). This result does not support the research hypothesis 
that adult patients will agree that it is important for them to keep track of their phe consumption 
daily but will keep track of their phe intake less often.  The correlation between how often 
patients test their blood phe level and how often their clinic recommends doing it was 
insignificantly positive (r = .481, p = .051). A post-hoc test was performed to determine the 
chance of Type II error occurring between how often patients test their blood phe level and how 
often their clinic recommends getting tested. Power was 0.566 with a 43% chance of a Type II 
error occurring. Subjects reporting testing their blood phe level on average once every three 
months. Where 9 = once a week and 1 = once every two years the average was 5.41 (SD = 2.57). 
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The importance of following their clinic’s recommendations for frequency of testing where 5 = 
strongly agree and 1 = strongly disagree averaged to be 4.41 (SD = .618). The correlation 
between subjects actual frequency of testing and the importance of following their clinic’s 
recommendations for how often they test blood phe levels was not significant (r = .319, p = 
.213).This result does not support the research hypothesis that adult patients will agree that it is 
important for them to test their blood phe level as recommended, but may actually test their 
blood phe level less often.   
Subjects who agreed that they have a good relationship with their clinic where 5 = 
strongly agree and 1 = strongly disagree had an average of 3.88 (SD = 1.11). There was a 
significant, positive correlation between subjects who agreed that they have a good relationship 
with their clinic and how frequently they test their blood phe level (r = .629, p = .007). There was 
also a significant correlation with these subjects and how often they follow their daily restriction 
(r = -.699, p = .002). In other words, the more they agreed that they had a good relationship with 
their clinic, the more often they followed their daily phe restriction. These subjects also felt that 
it was important to get tested as frequently as their clinic recommends (r = .530, p = .029). 
However, there was an insignificant positive correlation with how often they keep track of their 
phe (r = .474, p = .054). A post-hoc test was performed on this correlation and power was .561. 
There was a 44% chance that a Type II error occurred. 
 A significant and positive correlation was seen between how often patients keep 
track of their phe intake and how often they get their blood phe level tested (r = .724, p = .001). 
Subjects that tracked their phe intake more often tended to follow their daily protein restriction 
more often (r = -.642, p = .005) as in the coding, 1 = subjects follow the daily protein restriction 
every day. These subjects also felt it was important to get tested as often as their clinic 
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recommends (r = .590, p = .013). Age was also tested against how often phe intake is tracked and 
how often blood phe level is tested (r = .107, p = .684; r = -.081, p = .946, respectively). In 
addition, there were no other significant correlations when focusing on age.   
 All participating subjects belonged to one or more support groups for PKU, as shown in 
Table 3: Types of PKU Support Groups. A support group could be any place (whether online or 
in person) where patients can go and communicate with other PKU patients about PKU issues. 
Thirteen subjects belonged to the electronic mailing list, 11 subjects belonged to a facebook 
group related to PKU, ten subjects belonged to an online PKU site such as www.pku.com, five 
subjects belonged to a local PKU organization, and six subjects reported belonging to a clinic 
support group. Being a part of a clinic support group was defined as attending regular PKU 
events and talking to their metabolic dietitians and/or physicians regularly. Nine participants 
belonged to at least three of the different types of support groups. On average, subjects reported 
that they sometimes interact with other people in these groups. There were no significant 
correlations between how often subjects interact with their support groups and any aspects of 
their diet management practices.  
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 Table 1: Daily Phe Allowances  
Participant 
Daily Phe Allowance 
(mg)  Actual response if  
    
not originally in 
“mg” 
1 500   
2 500   
3 300   
4 400   
5 450   
6 300   
7 300   
8 315 21 exchanges 
9 450   
10 Aprox. 3750 
75 grams of 
protein 
11 350   
12 1000   
13 475   
14  Aprox. 2000 
40 grams of 
protein 
15 700   
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Table 2: Methods Used to Keep Track of Daily Phe Intake 
Participant Method used to  Does clinic support 
  keep track of phe this method? 
1 mg 
Any method that 
helps 
2 grams 
Any method that 
helps 
3 exchanges Agree 
4 mg Agree 
5 grams 
Any method that 
helps 
6 grams Unknown 
7 exchanges 
Any method that 
helps 
8 mg 
Any method that 
helps 
9 mg 
Any method that 
helps 
10 grams Disagree 
11 exchanges Disagree 
12 mg Agree 
13 grams Agree 
14 mg Agree 
15 grams 
Any method that 
helps 
16 mg Agree 
17 grams Agree 
 
 
 
 
 
 
 
 
18
 
 
Table 3: Types of PKU Support Groups 
 Types of Support  
Participant Email Facebook Site 
Local 
Org. Clinic 
1 x   x X x 
2 x   x   x 
3 x X x X x 
4 x         
5 x x x   x 
6 x x       
7 x x x X x 
8   x x X   
9 x x       
10 x         
11 x x       
12   x       
13 x x x     
14 x x x     
15   x x     
16     x     
17 x     X x 
Email = electronic mailing list; Facebook = any PKU related group on facebook; Site = any 
website dedicated to PKU and allows users to interact with each other; Local Org. = any local 
PKU organization where people get a chance to meet; Clinic = regularly talking to metabolic 
physician and/or dietitian and attending events regularly hosted by the clinic 
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Chapter 5:  Discussion 
 When assessing the amount of phenylalanine one can have daily, the only significant 
association was seen when looking at whether subjects thought  meeting in person with a support 
group will helped manage their diet. The lower the subject’s daily phe allowance, the more likely 
they will think that meeting in person with a PKU support group will help them manage their 
diet. This is expected because the lower someone’s daily phe allowance is, the more difficult it 
would be for them to come up with acceptable menu plans. Meeting with a support group could 
make determining a healthy, balanced meal plan easier.  
 As seen in Table 2: Methods Used to Keep Track of Daily Phe Intake, there is a variety 
of ways in which subjects kept  track of their phe intake. Eight of the 17subjects measure in mg 
of phe, seven subjects measured in grams of protein, and three used phe exchanges. This shows 
that different clinics may be recommending different methods of tracking. Each clinic may be 
only recommending one method for all of their patients or they could suggest tracking methods 
based on the patient’s preferences. In this study, the age of the subject did not significantly 
correlate with how they keep track of their phe intake. Van Rijn et al. (2008) found that subjects 
under ten years of age tended to use more exact counting methods. Subjects older than ten years 
of age and younger than 29 years old used estimation methods. The questions used in their study 
asked about specific situations, such as how would you measure phe if you were at a restaurant, 
where this study asked subjects about how they typically measure phe.  
As the results show, seven subjects reported that they feel that their clinic would support 
them in whatever method they found the most beneficial. Two subjects disagreed that it was the 
method that their clinic recommends.  This shows that metabolic health care professionals need 
to be more aware of what works for their patients. However, one subject who reported that they 
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disagree also reported that their clinic recommends getting blood phe levels tested once every 
three months, whereas they test themselves once every four months.  This subject also reported 
they are neutral/ambiguous on how good they feel their relationship is with their clinic.  
 Results did not support the hypothesis that when someone agrees to the importance of 
keeping track of their daily phe intake, they may actually keep track of their phe consumption 
less often. The reasoning was that adults would be more comfortable with the diet and would 
have developed habits to manage their phe level, meaning they would not need to keep track of 
their daily phe consumption regularly. This study found that there was no significant correlation 
between the two factors. In this study, subjects reported, on average, testing their blood phe level 
once every three months. This is slightly lower than findings by Bilginsory, Waitzam, Leonard, 
& Ernst (2005) as they had results that showed children between the ages of ten and eighteen 
tested themselves on average 6.6 times per year. More research needs to be done to determine if 
habits change from childhood to adulthood. There also was no association between how often 
subjects test their blood phe level and how often their metabolic clinic recommended getting 
tested. There was a 43% chance of a Type II error occurring in the correlation between subjects 
agreeing to the importance of keeping track of their daily phe intake and how often they actual 
kept  track of it. This means that while the results did not show a correlation, there was a 43% 
chance that there is one. More research needs to be done to determine any possible significance.  
 The second hypothesis was that adult patients will agree it is important for them to test 
their blood phe level as often as their clinic recommends, but they actually tested their blood phe 
level less often. The reason may be that adults who have grown up on the diet have developed 
familiar patterns and, when they have a routine, may feel more in control.  This in turn may 
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make getting their blood level tested not as big a priority. The results did not support this as the 
correlation was found insignificant. 
 Having a good relationship with their clinic may be an important factor to dietary 
management in those that have PKU. The third hypothesis was that subjects who feel they have a 
better relationship with their clinic are more likely to follow recommendations. The results from 
this study showed subjects that agreed that they have a good relationship were more likely get 
their blood phe levels tested more often and per clinic recommendations. This study also found 
that subjects who have a good relationship with their clinic were more likely to follow their daily 
restriction. These findings suggest that those who trust their metabolic health care providers are 
more likely to follow recommendations. However, the correlation was barely insignificant with 
subjects reporting a better relationship with their clinic and how often they keep track of their 
daily phe intake.  Type II error could have occurred due to a small sample size. More research 
needs to be done in order to determine a more definite correlation.  
 In this study, it was found that if a subject kept track of their phe intake more often, they 
were more likely to feel it is important to test their levels per clinic recommendations.  These 
subjects may also be more likely to get their blood phe level tested more often and follow their 
daily phe restriction more often.  Seeing as how patients who feel that they have a good 
relationship with their clinic may keep track of their phe intake more often, having a good 
relationship with their metabolic clinic could be an important factor in dietary management.  
However, more research would be needed to confirm it.  
 It appears that subjects were more likely to belong to an internet support group than one 
that meets in person. As areas of the United States may not have a local organization or support 
group available, patients will seek groups on the internet or the main PKU electronic mailing list. 
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Nine subjects reported to be in at least three types of support groups and all but two subjects 
were in more than one support group. As mentioned before, there was an inverse relationship 
between belonging to a support group that met in person and subject’s phe allowances.  This 
suggests that subjects with lower dietary phe allowances were more likely to seek a support 
group that meets in person. Even though there were no other significant correlations, more 
research should be done in this area as the majority of patients may belong to multiple support 
groups.  
Chapter 6:  Limitations 
 A limitation of this study was the small sample size. The exact number of adults with 
PKU in the United States is unknown due to a number of adults being off the diet for so long and 
not returning to their clinics. It is estimated that 1 in every 10,000 newborns in the United States 
are diagnosed with PKU and hundreds require a low protein diet to keep their blood phe levels 
normal (Schuett, 2008). There could have been a few reasons why there was little participation. 
Perhaps the channels used for recruiting were not enough and in the future it would best to 
contact clinics around the country and involve health professionals. Patients’ attitudes could 
possibly affect participation as well. Some patients do acknowledge their situation, but may do 
everything they can to be normal and they are not involved with anything PKU related. In the 
end, having a small sample size could have resulted in some of the correlations to be 
insignificant. More research needs to be done in this area as a larger sample size may impact 
these results.  
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Chapter 7: Future Research 
 This pilot study opens the door for future research that gives more insight for metabolic 
healthcare professionals. The results begin to show how important the relationship between the 
clinic and patient can be. Healthcare professionals can use this information to better understand 
what their patients are going through. These results also raise more questions such as: what can 
metabolic clinicians do to improve their relationship with patients and why don’t patients follow 
their diet management regularly even though they know it is important? More research will be 
able to further confirm findings in this study and will be able to expand on them.  
 
Chapter 8:  Conclusion 
 One of the major findings from this study is just how important the relationship between 
the patient and their metabolic clinic is. The greater their relationship was, the more likely they 
will keep better track of their phe intake. These subjects may test their blood phe level more 
often and follow their restriction more often. A stronger relationship may also help with other 
areas in management such as handling difficult situations and motivation to follow the diet. 
There also seems to be a variety of methods used to count phe intake. Perhaps there is no specific 
method that is best; each clinic needs to work with each patient individually to see what counting 
method will be most effective. The results also show that it would be beneficial if there were a 
uniform guideline of management as frequency of recommended testing blood phe levels seem 
to vary.  
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Appendix A: Approval from IRB 
IRB Number: 20110711827 EX 
Project ID: 11827 
Project Title: Attitudes of Management Practices in Patients with Phenylketonuria across the 
United States 
 
Dear Elizabeth: 
This letter is to officially notify you of the approval of your project by the Institutional Review 
Board (IRB) for the Protection of Human Subjects. It is the Board’s opinion that you have 
provided adequate safeguards for the rights and welfare of the participants in this study based on 
the information provided. Your proposal is in compliance with this institution’s Federal Wide 
Assurance 00002258 and the DHHS Regulations for the Protection of Human Subjects (45 CFR 
46) and has been classified as Exempt Category 2. 
You are authorized to implement this study as of the Date of Final Approval: 07/01/2011. 
1. Please include the IRB approval number (IRB# 20110711827 EX) in the email consent 
document. Please email a copy of these messages to irb@unl.edu for our records. If you need to 
make changes to the messages please submit the revised messages to the IRB for review and 
approval prior to using them 
We wish to remind you that the principal investigator is responsible for reporting to this Board 
any of the following events within 48 hours of the event: 
* Any serious event (including on-site and off-site adverse events, injuries, side effects, deaths, 
or other problems) which in the opinion of the local investigator was unanticipated, involved risk 
to subjects or others, and was possibly related to the research procedures; 
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* Any serious accidental or unintentional change to the IRB-approved protocol that involves risk 
or has the potential to recur; 
* Any publication in the literature, safety monitoring report, interim result or other finding that 
indicates an unexpected change to the risk/benefit ratio of the research; 
* Any breach in confidentiality or compromise in data privacy related to the subject or others; or 
* Any complaint of a subject that indicates an unanticipated risk or that cannot be resolved by 
the research staff. 
This project should be conducted in full accordance with all applicable sections of the IRB 
Guidelines and you should notify the IRB immediately of any proposed changes that may affect 
the exempt status of your research project. You should report any unanticipated problems 
involving risks to the participants or others to the Board.  
If you have any questions, please contact the IRB office at 472-6965. 
 
Sincerely, 
 
Becky R. Freeman, CIP 
For the IRB 
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Appendix B: Approval from IRB with changes 
 
 
October 5, 2011 Elizabeth Vlock Department of Nutrition and Health Sciences 909 S 181st Ave Elkhorn, NE 68022 
Kaye Stanek Krogstrand Department of Nutrition and Health Sciences 202J LEV, UNL, 68583-0806 IRB Number: 
Project ID: 11827 Project Title: Attitudes of Management Practices in Patients with Phenylketonuria across the 
United States  
Dear Elizabeth: The Institutional Review Board for the Protection of Human Subjects has completed its review of 
the Request for Change in Protocol submitted to the IRB. 1. It has been approved to recruit participants via word of 
mouth. You will contact as many people as you can and they will be encouraged to contact others. Those people 
who are interested will then contact you. 2. It has been approved to send the invitation to the PKU list-server as well. 
3. The revised recruitment messages have also been approved. We wish to remind you that the principal investigator 
is responsible for reporting to this Board any of the following events within 48 hours of the event: * Any serious 
event (including on-site and off-site adverse events, injuries, side effects, deaths, or other problems) which in the 
opinion of the local investigator was unanticipated, involved risk to subjects or others, and was possibly related to 
the research procedures; * Any serious accidental or unintentional change to the IRB-approved protocol that 
involves risk or has the potential to recur; * Any publication in the literature, safety monitoring report, interim result 
or other finding that indicates an unexpected change to the risk/benefit ratio of the research; * Any breach in 
confidentiality or compromise in data privacy related to the subject or others; or * Any complaint of a subject that 
indicates an unanticipated risk or that cannot be resolved by the research staff. This letter constitutes official 
notification of the approval of the protocol change. You are therefore authorized to implement this change 
accordingly. If you have any questions, please contact the IRB office at 472-6965. 
Sincerely,  Becky R. Freeman, CIP for the IRB 
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Appendix C: Letter Invite to PKU Electronic Mailing List 
Hello, 
My name is Elizabeth Vlock and I am a Master’s student in Nutrition and Health Sciences at University 
of Nebraska at Lincoln.  
Adults (ages 19 and older) with PKU are invited to participate in a research survey entitled “Attitudes of 
Management Practices of Adult Patients with Phenylketonuria across the United States.” The purpose of 
this study is to investigate attitudes of adults diagnosed with phenylketonuria (PKU) and how they relate 
to their actions of management therapy recommendations. This information will provide an insight to 
health care professionals who work with these patients. The results could be published in journals, books, 
or presented at conferences.  
The study will consist of filling out a short online survey. It should take between 15-20 minutes and you 
will be able to take it at your convenience. The first part of the survey will ask about various management 
behaviors and the second part will ask about your attitudes towards those behaviors.  
Please be assured that all of you response will be confidential and cannot traced back to you. Participation 
is voluntary and there is no known risk for taking it.  
If you know of anyone else who could participate in this survey please forward this message to them so 
they will have the opportunity to participate. Everybody’s perspective is important and will help 
healthcare professionals better understand the people they are treating.  
If you have any questions at all about the survey please call or e-mail me or Dr. Stanek-Krogstrand. If you 
have questions or concerns about the research please contact the Institutional Review Board at 402-472-
6965 or email them at irb@unl.edu . If you would be interested in participating please call or respond to 
this email saying you are willing to participate and a link to the survey will be sent to you. Thank you so 
much.  
Elizabeth Vlock, RD 
University of Nebraska 
Elizabeth.vlock@gmail.com 
(402) 212-6154 
 
Dr.  Kaye Stanek Krogstrand, RD, LMNT 
Associate Professor 
Nutrition and Health Sciences 
133 HECO 
University of Nebraska 
Lincoln, NE  68583 
402-472-5285 
Fax 402-472-1587 
email: kstanek1@unl.edu 
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Appendix D: Survey to Adult PKU Patients 
1) Age: _____________ 
2) Gender (circle one):  Male Female 
 If you are female: 
Are you pregnant? (Circle one) Yes / No 
 Weeks gestation? ______ 
 What is your current daily phenylalanine prescription? _______ 
 
Have you ever been pregnant? (Circle one) Yes / No 
 
For the next question, think about the time before your first pregnancy. 
 
1  2  3  4  5 
(Strongly disagree)     (Strongly agree) 
I feel that managing my low protein diet (getting blood phe level tested frequently, 
tracking daily phe intake, following the low protein diet, etc.) is more important during 
pregnancy 
 
1  2  3  4  5 
(Strongly disagree)     (Strongly agree) 
During pregnancy, I strictly followed my clinic’s recommendations, followed the low 
protein restrictions, tested blood phe levels frequently, and improved my overall 
management of PKU 
 
  
3) In which region of the United States do you live in? (Check the box that applies) 
  West Coast 
  Southwest 
  Midwest 
  Northeast 
  Southeast 
   
4) What is the recommended amount of phenylalanine you are allowed per day? 
_________________ 
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5) How often do you follow your recommended daily protein restriction?  
a) Everyday 
b) Often – most days of the week 
c) Sometimes  
d) Rarely 
e) Never 
f) Only around the days that I test my phe level 
 
6) Which method is your preferred method of keeping track of the amount of phenylalanine 
you consume per day? 
a) I count my phes in milligrams (mg) 
b) I count by grams of protein 
c) I count by phe exchanges 
d) I count by another way: ___________________________ 
 
7) This is the method that I feel my clinic recommends. 
a) Agree 
b) Disagree 
c) Unknown 
d) I feel my clinic supports any method that helps me 
 
8) How often do you keep track of your phe intake? 
a) I keep track of my phe intake everyday 
b) I keep track of my phe intake most days 
c) I keep track of my phe intake sometimes 
d) I keep track of my phe intake rarely 
e) I only keep track of my phe intake around the days that I get my phe level tested 
 
9) How often do you typically get your blood phe level tested? 
a) Once per week 
b) 2-3 times per month 
c) Once per month 
d) Once every 2-3 months 
e) Other: __________________ 
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10) How often does your clinic normally recommend you get your blood phe level tested?  
a) Once per week 
b) 2-3 times per month 
c) Once per month 
d) Other: ___________________ 
e) Unknown 
 
11) In the last 6 months, how many times have you gotten your blood phe level tested?  
a) 0-2 times 
b) 3-6 times 
c) 7-10 times 
 
12) How often do you see your clinic physician, registered dietitian, or other healthcare 
professional for a “PKU checkup”? 
a) Two or more times a year 
b) Once a year 
c) Once every two years 
d) Other: ________________ 
 
13) Check all the types of healthcare professionals that meet with you during your PKU 
checkup. 
  
Physician 
 Dietitian 
 Nurse 
 Psychologist 
 Other: _______________ 
 
 
For the following questions, a support system is a group of people that talk regularly about PKU 
and offers help or advise to others who need it.  
 
14) Check which support groups or systems you belong to (check all that apply): 
 PKU list serv 
 Facebook group (or other internet groups, such yahoo groups)  
 Online PKU site (such as, but not limited to, www.pku.com or www.cookforlove.org) 
 A local PKU organization 
Your PKU clinic (attending regular events, talking to healthcare professionals regularly, 
etc.)  
 Other (you may list more than one) : _____________________________ 
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15) How often do you interact with other people in these support systems (such as asking 
questions or responding to comments or questions)?  
a) Very often 
b) Often 
c) Sometimes 
d) Rarely 
e) Never 
 
For the next set of questions, circle the number that best represents how you feel with one 
meaning you strongly disagree and five meaning you strongly agree.  
 
1  2  3  4  5 
(Strongly disagree)     (Strongly agree) 
16) It is important for me to keep track of my phe intake everyday 
1  2  3  4  5 
(Strongly disagree)     (Strongly agree) 
17) It is important for me to follow my protein restriction daily 
 
1  2  3  4  5 
(Strongly disagree)     (Strongly agree) 
18) It is important for me to get tested frequently (as often as my clinic recommends) 
 
1  2  3  4  5 
(Strongly disagree)     (Strongly agree) 
19) I feel I have a good relationship with my PKU clinic (includes relationship with 
registered dietitian, physician, and other healthcare professionals)  
 
1  2  3  4  5 
(Strongly disagree)     (Strongly agree) 
20) It is important to have a good relationship with my PKU clinic to maintain healthy 
phe levels 
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1  2  3  4  5 
(Strongly disagree)     (Strongly agree) 
 
21) I believe that belonging to a support group helps me manage my diet and maintain 
healthy phe levels 
 
 
1  2  3  4  5 
(Strongly disagree)     (Strongly agree) 
 
22) Belonging to a support group that meets in person will help me manage my diet more 
than one that does not meet in person 
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Appendix E: Summary of Significant Correlations 
Correlations r values p values 
Patients who feel they have a 
good relationship with their 
clinic are more likely to test their 
blood phe level more often 
 
0.629 0.007 
Patients who feel they have a 
good relationship with their 
clinic are more likely to follow 
their daily protein restriction  
 
-0.699 0.002 
Patients who feel they have a 
good relationship with their 
clinic are more likely to see the 
importance of getting their 
blood phe level tested per clinic 
recommendations 
 
0.530 0.029 
The lower a subject’s daily phe 
allowance, the more likely they 
will feel that meeting with a 
support group in person will help 
them manage their diet 
 
-0.589 0.044 
The more often subjects keep 
track of their daily phe intake the 
more often they will get their 
blood phe level tested 
 
0.724 0.001 
The more often subjects keep 
track of their daily phe intake the 
more often subjects will follow 
their daily protein restriction 
 
-0.642 0.005 
The more often subjects keep 
track of their daily phe intake the 
more they will realize the 
importance of getting their 
blood phe level tested per clinic 
recommendations 
 
0.590 0.013 
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